AEBP1 and metabolic dysfunction-associated steatohepatitis: AEBP1 was recently found to be expressed in hepatic stellate cells (HSCs) and shown to complex with frizzled-8 and low-density lipoprotein-related receptor 6 to activate canonical WNT signaling, resulting in activation of HSCs in mouse models of NASH [10].